V3 Biotechnologies Private Limited
About V3 Biotechnologies Private Limited
Data last updated:
V3 Biotechnologies Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 August 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2004PTC099487.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.65 Lakh. It is led by directors Tarasankar Bhattacharjee and Ajit Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹17,500, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹168 (net margin 1%) and EBITDA of ₹200 (EBITDA margin 1.1%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
V3 Biotechnologies Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10 Govt Place East, (22/1 Ezra Mansions), Kolkata, West Bengal, India – 700069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of V3 Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of V3 Biotechnologies Private Limited
FY 2025 filings availableV3 Biotechnologies Private Limited reported revenue of ₹17,500 (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 19%. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹200 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹168 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of V3 Biotechnologies Private Limited, buy the company report.
Board of directors of V3 Biotechnologies Private Limited
V3 Biotechnologies has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Agrawal Also directs: Netgro Farms Private Limited, Bio-Caps India Limited, Kohinoor Medicare Private Limited. and 5 more | Additional Director | 11 Feb 2022 | 4 Years 8 Months | Current |
| Tarasankar Bhattacharjee Also directs: Netgro Farms Private Limited, Kohinoor Medicare Private Limited., Bio-Caps India Limited and 5 more | Director | 25 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
V3 Biotechnologies Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| People's Pharmaceuticals Private Limited | ₹19,100 (FY 2025) | Bhopal, Madhya Pradesh, India | ||||
| D. M. Medicos Private Limited | ₹18,926 (FY 2025) | 11.0% | Delhi, India | |||
| Paramount Pharma Care Private Limited | ₹18,700 (FY 2023) | 13.0% | Siliguri, West Bengal, India | |||
| Symlux Pharmaceuticals Private Limited | ₹18,370 (FY 2023) | -77.0% | Thane, Maharashtra, India | |||
| Bonafide Nutrition Private Limited | ₹18,132 (FY 2024) | -98.0% | Yamuna Nagar, Haryana, India | |||
| V3 Biotechnologies Private Limitedthis company | ₹17,500 (FY 2025) | ₹168 | 1% | 8.0% | Kolkata, West Bengal, India | |
| D I Laboratories Ltd | ₹17,240 (FY 2024) | -97.0% | Kolkata, West Bengal, India | |||
| DMK Ventures Private Limited | ₹17,000 (FY 2025) | -70.0% | Ahmedabad, Gujarat, India | |||
| GSR International Private Limited | ₹16,855 (FY 2017) | 77.0% | New Delhi, Delhi, India | |||
| Monozyme India Limited | ₹16,600 (FY 2025) | 14.0% | Secunderabad, Telangana, India | |||
| Sanjhi Foodco Industries Private Limited | ₹16,437 (FY 2025) | 0.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of V3 Biotechnologies Private Limited, buy the company report.
Shareholding
The shareholding of V3 Biotechnologies Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of V3 Biotechnologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving V3 Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for V3 Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for V3 Biotechnologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
V3 Biotechnologies Private Limited has 8 board changes on record since 2012: 2 appointments and 6 cessations. The latest: Anurag Sonthalia ceased to be Additional Director on 23 Sep 2025.
Frequently asked questions
V3 Biotechnologies is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 August 2004 (22+ years old) and is registered under CIN U24239WB2004PTC099487.
V3 Biotechnologies has 2 current directors:
- Ajit Agrawal - Additional Director
- Tarasankar Bhattacharjee - Director
The latest financial statements of V3 Biotechnologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of V3 Biotechnologies is U24239WB2004PTC099487. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
V3 Biotechnologies was incorporated on 18 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of V3 Biotechnologies by revenue are People's Pharmaceuticals Private Limited, D. M. Medicos Private Limited, Paramount Pharma Care Private Limited, Symlux Pharmaceuticals Private Limited, Bonafide Nutrition Private Limited and 5 more, all in the Pharma industry (Formulations).
Anurag Sonthalia ceased to be Additional Director on 23 Sep 2025. Tarasankar Bhattacharjee was appointed as Director on 25 Aug 2025. Manju Sonthalia ceased to be Additional Director on 12 Apr 2024. V3 Biotechnologies has 8 board changes on record in total.
The registered office of V3 Biotechnologies is at 10 Govt Place East, 221 Ezra Mansions, Kolkata, West Bengal, India – 700069.
V3 Biotechnologies operates in the pharma industry, in the drug formulation and development segment.
The compliance status of V3 Biotechnologies is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
V3 Biotechnologies can be reached at its registered office: 10 Govt Place East, 221 Ezra Mansions, Kolkata, West Bengal, India – 700069.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
